Carbaglu 200 Mg 200 mg Dispersible tablets.
PDF Leaflet Revision Date: 29 September 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of hyperammonaemia due to specific metabolic disorders.
Dosage (summary)
Initial dose: 100 mg/kg, up to 250 mg/kg; adjust to maintain normal ammonia levels.
Onset of Action / Duration
Onset: within hours, Duration: varies based on individual response.
Special Populations
- Renal impairment
- Paediatric population
Pregnancy & Breastfeeding
Safety in pregnancy not established; contraindicated in breastfeeding.
Contraindications
- Hypersensitivity
- Breastfeeding
Common side effects
- Increased transaminases
- Increased sweating
- Bradycardia
- Diarrhoea
- Vomiting
Counselling Points
- Monitor for side effects
- Adjust dose based on ammonia levels
- Administer before meals
Serious warnings
- Therapeutic monitoring of ammonia levels required
- Caution in renal impairment
Important Disclaimer
The Carbaglu 200 Mg 200 mg Dispersible tablets. professional information leaflet below is the property of Equity Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
